M&A Deal Summary |
|
|---|---|
| Date | 2023-11-24 |
| Target | CartiHeal |
| Sector | Medical Products |
| Buyer(s) | Smith & Nephew |
| Sellers(s) | Bioventus |
| Deal Type | Divestiture |
| Deal Value | 330M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1856 |
| Sector | Medical Products |
| Employees | 18,000 |
| Revenue | 5.2B USD (2022) |
Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, the United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 34 of 34 |
| Sector (Medical Products) | 23 of 23 |
| Type (Divestiture) | 9 of 9 |
| Country (Israel) | 1 of 1 |
| Year (2023) | 1 of 1 |
| Size (of disclosed) | 5 of 15 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-01 |
Smith+Nephew - Two Wound-healing Cell Therapy Assets
Watford, United Kingdom Smith+Nephew - Two Wound-healing Cell Therapy Assets EpiDex®, is an autologous epidermal equivalent that provides a surgery-free approach to healing chronic venous leg ulcers (VLUs). Healiva®002, is an off-the-shelf allogeneic cell therapy that has previously demonstrated clinical efficacy in healing VLUs that are resistant to standard treatments. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 2011 |
| Sector | Medical Products |
| Employees | 1,040 |
| Revenue | 512M USD (2022) |
Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Medical Products) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| Country (Israel) | 1 of 1 |
| Year (2023) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-04 |
CartiHeal
Kfar-Saba, Israel CartiHeal is a privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal founded in 2009 and is based in Kfar-Saba, Israel. |
Buy | $315M |
